Ellevest Inc’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$740K Sell
10,726
-10,964
-51% -$757K 0.12% 127
2025
Q1
$1.51M Sell
21,690
-954
-4% -$66.2K 0.1% 70
2024
Q4
$1.95M Sell
22,644
-824
-4% -$70.9K 0.11% 57
2024
Q3
$2.79M Buy
23,468
+357
+2% +$42.5K 0.15% 49
2024
Q2
$3.3M Buy
23,111
+1,213
+6% +$173K 0.2% 42
2024
Q1
$2.81M Buy
21,898
+392
+2% +$50.3K 0.17% 45
2023
Q4
$2.22M Buy
21,506
+122
+0.6% +$12.6K 0.15% 45
2023
Q3
$1.94M Buy
21,384
+1,716
+9% +$156K 0.15% 42
2023
Q2
$1.59M Buy
19,668
+362
+2% +$29.3K 0.12% 48
2023
Q1
$1.54M Sell
19,306
-76
-0.4% -$6.05K 0.12% 48
2022
Q4
$1.31M Buy
19,382
+3,380
+21% +$229K 0.11% 46
2022
Q3
$797K Sell
16,002
-3,016
-16% -$150K 0.08% 58
2022
Q2
$1.06M Buy
19,018
+1,820
+11% +$101K 0.1% 48
2022
Q1
$955K Buy
17,198
+3,892
+29% +$216K 0.08% 58
2021
Q4
$745K Buy
13,306
+570
+4% +$31.9K 0.07% 70
2021
Q3
$611K Buy
12,736
+1,664
+15% +$79.8K 0.06% 76
2021
Q2
$464K Buy
11,072
+1,978
+22% +$82.9K 0.05% 93
2021
Q1
$307K Buy
9,094
+840
+10% +$28.4K 0.04% 130
2020
Q4
$288K Buy
8,254
+2,842
+53% +$99.2K 0.04% 112
2020
Q3
$188K Sell
5,412
-136
-2% -$4.72K 0.03% 141
2020
Q2
$182K Buy
5,548
+1,666
+43% +$54.7K 0.04% 123
2020
Q1
$117K Buy
3,882
+2,574
+197% +$77.6K 0.03% 124
2019
Q4
$38K Buy
1,308
+1,242
+1,882% +$36.1K 0.01% 256
2019
Q3
$2K Sell
66
-282
-81% -$8.55K ﹤0.01% 343
2019
Q2
$9K Buy
+348
New +$9K ﹤0.01% 257